Objectives D-cycloserine (DCS) is an important second-line drug used to treat multi-drug 23 resistant (MDR) and extensively drug-resistant (XDR) tuberculosis. However, the 24 mechanisms of resistance to DCS are not well understood. Here we investigated the 25 molecular basis of DCS resistance using in vitro isolated resistant mutants of Mycobacterium 26
Introduction 45 D-Cycloserine (DCS) is a cyclic analog of D-alanine and is a broad-spectrum antibiotic that 46 inhibits the growth of Gram-positive and Gram-negative bacteria. Although DCS has 47 psychiatric and nervous system adverse reactions, it displays no cross-resistance with any 48 other known antitubercular drugs 1 . DCS is an important second-line drug for the treatment of 49 multi-drug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis 1 , and is 50 currently classified as a Group C agent for the treatment of MDR-TB treatment by WHO 2 . 51 52 Since DCS is a structural analog of D-alanine, enzymes whose substrates are D-alanine are 53 the drug targets in mycobacteria [3] [4] [5] . These enzymes include D-alanine racemase (Alr) and d-54 alanine:d-alanine ligase (Ddl), which are required for the synthesis of peptidoglycan in the 55 mycobacterial cell wall. Overexpression of alr and ddl has been shown to cause resistance to 56 DCS in M. smegmatis 6, 7 . Moreover, single nucleotide polymorphisms in these genes were 57 also found in resistant M. tuberculosis [8] [9] [10] . Consistent with the cell wall peptidoglycan being 58 a target of DCS, previous studies have shown that DCS competitively inhibits both Alanine 59 racemase (Alr) and D-alanine-D-alanine ligase (Ddl) 6, 11 . However, more recent metabolomic 60 study showed that Ddl is a primary target of DCS that is preferentially inhibited over alanine 61 racemase (Alr) in M. tuberculosis 12 . In addition, CycA is a transporter protein of D-alanine, 62 D-serine and glycine D-serine/alanine/glycine 13 , and its single nucleotide polymorphism 63 (SNP) may partially contribute to the natural resistance to D-cycloserine in BCG 10, 14 . ald 64 (Rv2780), encoding L-alanine dehydrogenase, was the fourth gene in M. tuberculosis, whose 65 mutation was found in DCS resistant clinical isolates 10 . However, mutations in cycA and ald 66 only contribute to very low level resistance, and Ddl mutation was rarely found in studies 67 without known phenotype in MDR/XDR-TB strains 10 Preparation kits (Illumina, USA) following manufacturer's instruction. For each isolate, 500 104 barcodes were trimmed. Single-nucleotide variants (SNVs) and insertions and deletions 106 (InDels) ranging from 1 to 5 bp were sorted and called at a minimum coverage of 4 reads 107 using M. tuberculosis H37Rv genome (NC_018143.1) as a reference. Mutations in PE/PPE 108 family genes and regions having repetition sequences were excluded from the analysis. 109
Mutations in the parent strain M. tuberculosis H37Rv comparing with the genome online 110 (NC_018143.1) were also excluded from the analysis. 111
112

PCR and DNA sequencing 113
The genomic DNA from DCS-resistant mutants isolated in vitro was then subjected to PCR 114 amplification using primers listed in Table 1 . The PCR products were obtained using the 115 amplification parameters listed in Table 1 and sequenced by Sanger method to confirm the 116 mutations in these genes in selected mutants. 117 118 Results and discussion 119 120
Isolation of M. tuberculosis H37Rv mutants resistant to DCS 121
The cycloserine MIC for the sensitive M. tuberculosis H37Rv parent strain was found to be 122 below 20 mg/L. To isolate mutants resistant to DCS, about 10 8 M. tuberculosis bacteria were 123 plated on 7H11 plates containing different concentrations of DCS (20, 40, 80, 160, 320 124 mg/L). After 4 weeks of incubation, no mutants grew on plates containing DCS higher than 125 80 mg/L. We found that only two mutants DT61-1 and DT69-1 grew on plates containing 40 126 mg/L cycloserine, and 35 mutants were obtained on plates containing 20 mg/L cycloserine. 127
The mutation frequency of resistant mutants to 20 mg/L cycloserine was found to be about 2 128
x 10 -8 . 129
130
Mutations identified in DCS resistant mutants by WGS 131
WGS of 18 DCS resistant mutants showed that 16 isolates had only 1 mutation (SNV or 132 InDels) and 2 isolates had 2 mutations. Totally 17 different gene mutations were identified in 133 18 mutants (Table 2) , and it is of interest to note that none of these mutations were dominant. 134
Nonsynonymous mutations in alr (rv3423c), rv0059, betP (rv0917), rv0221, rv1403c, 135 rv1683, rv1726, gabD2 (rv1731), rv2749, sugI (rv3331), hisC2 (rv3772), single mutation in 136 5' intergenic region of rv3345c and rv1435c, and insertion in 3' region of rv0759c were 137 identified as the solo mutation in their respective cycloserine-resistant mutants, suggesting 138 these mutations associated with cycloserine resistance are highly diverse. In addition, one 139 mutant (DT61-1) had two mutations in alr (rv3423c) as well as a -52 G-T change in rv3345c 140 (hypothetical protein), while the other mutant (DT3-2) had double mutations in both rv2831 141 and rv3690 (Table 2) . Ten mutation genes, rv3690, rv0739c, rv1403c, rv1435c, rv2831, 142 rv1726, rv1731, rv3331, rv3772 and alr were verified by the Sanger sequencing method 143 using primers and PCR conditions as described in Table 1 . 144
145
The two mutants DT61-1 and DT69-1 which had higher resistance to DCS (40 mg/L) had the 146 same nonsynonymous mutation in alanine racemase gene alr, (nucleotide change C1030T, causing amino acid change of D344N). Except for alr, which is known to be involved in DCS 148 resistance 6, 7 , the remaining 16 are novel and have not been reported previously. These 16 149 mutations include 3 lipid metabolism (Rv0221, Rv1683, Rv2831), 2 transport proteins (BetP, 150 SugI), 1 toxin/antitoxin (Rv0059), 3 intermediary metabolism and respiration (Rv1726, gabD2, 151 HisC2), 1 methyltransferase (Rv1403c), 1 PE family protein (PE_PGRS50), and 5 unknown 152 hypothetical proteins (Rv0759c, Rv1435c, Rv2749, Rv3345c, Rv3690). rv0059 is toxin of a 153 TA-module (Rv0059 and Rv0060) 19 . 154
155
One mutant (DT21-5) had an N-terminal stop codon mutation in the sugI gene, which resulted 156 in complete loss of its protein function ( Table 2 ). The sugI encodes a probable sugar-transport 157 integral membrane protein in M. tuberculosis 20 . Since the cycloserine structure is similar to 158 natural furanose and sugI is the solo mutation detected in the genome, DCS could use SugI as 159 the transporter for intake into the cell. The loss of function mutation in sugI could result in a 160 lower uptake of cycloserine inside the cell and therefore leading to higher resistance to DCS. 161 This is consistent with the previous observation that a transport protein involved in alanine and 162 serine uptake was implicated in the uptake and resistance of DCS 5 . betP was the other transport 163 protein whose SNV was detected in a different mutant DT71-1. BetP transports molecules with 164 a quaternary ammonium group like betaine, carnitine and choline. Whether mutations in SugI 165
and BetP could cause resistance through alterating the transport of DCS remains further 166 investigation in future studies. 167 168 Five genes encoding hypothetical proteins were identified in the mutants, including intergenic 169 SNVs of rv3345c, rv0759c and rv1435c, and non-synonymous SNVs of rv3690 and rv2749. 170
Rv3345c seems to be a stress response protein, as it is regulated by sigD in strain H37Rv 21 . 171
The mutation is located in the promoter region of rv3345c, which may alter its expression. 172
Rv3690 is a probable conserved membrane protein, and its expression was found to be elevated 173 in MDR-TB strains 22 stress [26] [27] [28] [29] [30] . Mutation in rv1403c impaired its growth phenotype in acidified 7H9 medium 186 (pH5.5) compared with the wild type strain 30 . rv1726 encodes an FAD-binding dehydrogenase 187 and its mutation was identified in 2 of 16 resistant mutants (DT81-2 and DT81-2-1) ( Table 2) . 188
This oxidoreductase is structurally similar to 6-hydroxy-D-nicotine oxidase (6-HDNO) of 
